RHEUMATIC DISEASE CLINICS OF NORTH AMERICA

Scope & Guideline

Navigating the complexities of rheumatology for better outcomes.

Introduction

Immerse yourself in the scholarly insights of RHEUMATIC DISEASE CLINICS OF NORTH AMERICA with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN0889-857x
PublisherW B SAUNDERS CO-ELSEVIER INC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1987 to 2024
AbbreviationRHEUM DIS CLIN N AM / Rheum. Dis. Clin. North Am.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899

Aims and Scopes

The 'Rheumatic Disease Clinics of North America' journal serves as a vital resource for clinicians and researchers in the field of rheumatology, focusing on a broad spectrum of topics related to the diagnosis, treatment, and management of rheumatic diseases. Its articles emphasize clinical practices, emerging therapies, and the integration of interdisciplinary approaches to enhance patient care.
  1. Clinical Management of Rheumatic Diseases:
    The journal extensively covers practical approaches to the diagnosis and management of various rheumatic conditions, including systemic lupus erythematosus, rheumatoid arthritis, and vasculitis.
  2. Interdisciplinary Care and Collaboration:
    There is a consistent emphasis on the importance of interdisciplinary care in rheumatology, highlighting collaborations amongst healthcare providers to improve patient outcomes.
  3. Emerging Therapies and Biomarkers:
    The journal regularly explores new therapeutic modalities and biomarkers relevant to rheumatologic diseases, providing insights into future treatment directions.
  4. Patient-Centered Care:
    A significant focus is placed on the patient experience, incorporating patient-reported outcomes and mental health considerations into the management of rheumatic diseases.
  5. Environmental and Genetic Factors:
    Research articles also delve into the environmental and genetic factors influencing the onset and progression of rheumatic diseases, acknowledging their role in treatment and prevention.
The journal has increasingly focused on several emerging themes that reflect the latest advancements and areas of interest in rheumatology. These trends indicate a shift towards more comprehensive and integrative approaches in the treatment and study of rheumatic diseases.
  1. Immune Checkpoint Inhibitors and Their Effects:
    Recent publications have highlighted the implications of immune checkpoint inhibitors in rheumatology, particularly their adverse effects on patients with pre-existing autoimmune conditions, signaling a growing area of interest in this intersection.
  2. Mental Health and Chronic Illness:
    There is an emerging focus on the psychological aspects of living with rheumatic diseases, including mental health considerations and the impact of chronic illness on quality of life.
  3. Pediatric Rheumatology:
    An upward trend in pediatric rheumatology topics has been observed, emphasizing the unique challenges and advancements in treating rheumatic diseases in children and adolescents.
  4. Patient Engagement and Experience:
    The journal is increasingly publishing articles that emphasize the importance of patient engagement, shared decision-making, and the incorporation of patient experiences into clinical practice.
  5. Environmental Factors in Disease Management:
    There is a growing recognition of environmental risk factors related to rheumatic diseases, with research exploring how these factors can influence disease onset and progression.

Declining or Waning

While the journal has maintained a strong focus on various aspects of rheumatology, certain themes have become less prominent in recent publications. This decline may indicate shifting interests or advancements in the field that have rendered some previously discussed topics less relevant.
  1. Traditional Pharmacological Approaches:
    There has been a noticeable decrease in publications focusing solely on traditional pharmacological treatments for rheumatic diseases, as the field shifts towards more innovative and personalized medicine approaches.
  2. Basic Science and Mechanistic Studies:
    Research that primarily explores basic science and mechanistic studies related to rheumatic diseases appears to be waning in favor of clinical applications and patient-centered research.
  3. Generalized Guidelines without Specificity:
    The journal has moved away from generic treatment guidelines and recommendations, favoring more nuanced, condition-specific management strategies that reflect the complexity of individual patient needs.

Similar Journals

RHEUMATOLOGY INTERNATIONAL

Elevating the standards of rheumatological science.
Publisher: SPRINGER HEIDELBERGISSN: 0172-8172Frequency: 12 issues/year

Rheumatology International, published by Springer Heidelberg, is a prestigious journal that focuses on innovative research in the field of rheumatology and immunology. Established in 1981, this peer-reviewed journal has contributed significantly to advancing our understanding of autoimmune disorders, clinical approaches, and therapeutic interventions. It holds a commendable Q2 ranking in the categories of Immunology, Immunology and Allergy, and Rheumatology as of 2023, showcasing its influence and importance within these disciplines. With a robust Scopus ranking—positioned 14 out of 73 in Medicine Rheumatology—it caters to a diverse audience of researchers, clinicians, and students committed to improving patient care and treatment modalities. Although it does not currently offer open access options, the journal remains a vital resource for insights on contemporary challenges and breakthroughs in rheumatological research, published from its base in Heidelberg, Germany.

Arthritis & Rheumatology

Fostering Insights for a Healthier Tomorrow
Publisher: WILEYISSN: 2326-5191Frequency: 12 issues/year

Arthritis & Rheumatology is a leading journal dedicated to the advancement of knowledge in the fields of rheumatology, immunology, and allergy. Published by WILEY in the United Kingdom, this prestigious journal boasts an impressive impact factor and a prominent reputation, ranking in the Q1 category across multiple disciplines, including Immunology and Rheumatology. With its high ranking of 4th out of 73 in Rheumatology and notable standings in related fields, it serves as a crucial platform for researchers, healthcare professionals, and scholars to disseminate groundbreaking findings. The journal embraces an Open Access model, enhancing the accessibility of vital research to a global audience and ensuring that knowledge dissemination is maximized. Since its inception in 2014, Arthritis & Rheumatology has been at the forefront of impactful research, fostering collaboration and innovation in tackling complex challenges within these medical disciplines. Researchers looking to explore the latest advancements and engage with cutting-edge studies in these fields will find this journal to be an essential resource.

BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY

Elevating Standards through Rigorous Research
Publisher: ELSEVIER SCI LTDISSN: 1521-6942Frequency: 4 issues/year

BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, published by Elsevier, stands as a premier journal in the field of rheumatology, holding a prestigious Q1 ranking in both Medicine (miscellaneous) and Rheumatology categories as of 2023. With an ISSN of 1521-6942 and an E-ISSN of 1521-1770, the journal is dedicated to advancing clinical knowledge and practice through the dissemination of high-quality, peer-reviewed research. Since its inception in 1995, this journal has provided a platform for researchers, clinicians, and healthcare providers to share significant advancements, best practices, and innovative insights that shape the standards of care in rheumatology. The commitment to open access publishing reflects its mission to broaden the reach of critical research findings, ensuring that professionals across the globe can access valuable information in this vital field. The journal's impressive Scopus ranking, positioned at #10 out of 73 in Medicine-Rheumatology, alongside its notable impact factor, underscores its importance and influence in guiding clinical practice and policy in rheumatologic conditions. By engaging with this journal, readers can stay informed about emerging trends and evidence-based strategies that are crucial for improving patient outcomes.

Rheumatology Advances in Practice

Empowering rheumatology through innovation and education.
Publisher: OXFORD UNIV PRESSISSN: Frequency: 2 issues/year

Rheumatology Advances in Practice, published by Oxford University Press, is a vital open-access journal dedicated to advancing research and education in the field of rheumatology. With an E-ISSN of 2514-1775 and an impressive open access model established since 2017, this journal facilitates the dissemination of cutting-edge knowledge and innovative practices to a global audience. It has garnered recognition within the academic community, holding a Q3 classification in Rheumatology for 2023, which reflects its contribution to the evolving landscape of rheumatological research. The journal aims to present high-quality, peer-reviewed articles that explore the latest findings, advancements, and clinical applications in rheumatology, making it an essential resource for researchers, healthcare professionals, and students alike. By bridging the gap between research and practice, Rheumatology Advances in Practice plays a significant role in improving the care of patients with rheumatological conditions, promoting evidence-based approaches to clinical challenges.

Rheumatology & Autoimmunity

Unveiling breakthroughs in rheumatological diseases.
Publisher: WILEYISSN: 2767-1410Frequency: 4 issues/year

Rheumatology & Autoimmunity, published by WILEY, is an emerging academic journal that delves into the intricacies of rheumatological diseases and autoimmune disorders, providing a critical platform for researchers and practitioners within the field. With an ISSN of 2767-1410 and E-ISSN 2767-1429, the journal aims to disseminate cutting-edge research in both clinical and laboratory settings, enhancing knowledge and understanding among professionals and scholars. Although currently classified in Q4 for Immunology and Allergy, and Q3 for Internal Medicine and Rheumatology as of 2023, the journal is positioned for growth and greater visibility in the scientific community. The three-year publishing span from 2021 to 2024 signifies a commitment to addressing contemporary issues and fostering collaboration among various disciplines related to immunology. As an open access journal, it provides wide accessibility, ensuring that groundbreaking research is available to a broad audience. This journal is poised to become a vital resource for those dedicated to advancing the understanding and treatment of autoimmune conditions.

European Journal of Rheumatology

Empowering Knowledge for Global Rheumatology Experts
Publisher: AVESISSN: 2147-9720Frequency: 4 issues/year

European Journal of Rheumatology is a premier, peer-reviewed journal that has been paving the way for innovative research and in-depth analysis in the field of rheumatology since its launch. Published by AVES, this Open Access journal has been accessible to researchers, professionals, and students worldwide since 2014, promoting the sharing of valuable knowledge on rheumatic diseases and their treatment. With an ISSN of 2147-9720 and an E-ISSN of 2148-4279, it provides a prominent platform for groundbreaking studies and clinical evaluations that bridge scientific discovery with practical application. The journal’s mission is to enhance the understanding of rheumatological conditions and facilitate advancements in therapeutic strategies, making it an essential resource for anyone devoted to the improvement of patient care in this dynamic field. The European Journal of Rheumatology is committed to upholding the highest standards of scholarly publishing and aims to foster collaboration among researchers and practitioners across Europe and beyond.

Reumatologia

Bridging academia and practice in Immunology and Allergy.
Publisher: TERMEDIA PUBLISHING HOUSE LTDISSN: 0034-6233Frequency: 6 issues/year

Reumatologia is a dedicated open-access journal published by TERMEDIA PUBLISHING HOUSE LTD that has been serving the global scientific community since 2005. The journal focuses on the fields of Rheumatology, Immunology, and Allergy, providing a rich platform for researchers and practitioners to share innovative findings, clinical insights, and methodologies. With its roots tracing back to the early 1960s and a steady convergence of quality content through 2024, Reumatologia has secured a place in the academic landscape, currently holding a Q4 rating in Immunology and a Q3 rating in both Immunology and Allergy and Rheumatology categories for 2023. While the journal ranks #42 out of 73 in the Medicine - Rheumatology category, its open-access model ensures that research is widely disseminated, enhancing visibility and accessibility to vital knowledge that shapes therapeutic practices. Located in Poznan, Poland, Reumatologia remains a pivotal source of credible research, fostering collaboration among academics, healthcare professionals, and students internationally.

Acta Reumatologica Portuguesa

Exploring the frontiers of rheumatology and general medicine.
Publisher: PUBLISAUDE-EDICOES MEDICAS LDAISSN: 0303-464XFrequency: 4 issues/year

Acta Reumatologica Portuguesa is a premier open access journal dedicated to the field of rheumatology and general medicine, published by PUBLISAUDE-EDICOES MEDICAS LDA since its inception in 1973. Situated in Portugal, this journal aims to disseminate high-quality research findings, clinical studies, and reviews that contribute to the understanding and management of rheumatic diseases. Despite its current Q4 ranking in both Medicine (miscellaneous) and Rheumatology, it serves as a vital platform for researchers and professionals aiming to share innovative insights and clinical practices within a rapidly evolving field. Researchers and medical professionals will find valuable information that can significantly influence their work, given the journal’s commitment to accessible knowledge through its open access model. By prioritizing collaboration and knowledge-sharing, Acta Reumatologica Portuguesa continues to engage with issues of critical relevance in rheumatology, appealing to a diverse audience of scholars and healthcare practitioners.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY

Connecting research and clinical excellence.
Publisher: CLINICAL & EXPER RHEUMATOLOGYISSN: 0392-856XFrequency: 6 issues/year

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY is a prestigious journal published by CLINICAL & EXPER RHEUMATOLOGY, dedicated to advancing the field of rheumatology and immunology. With a rich history dating back to 1983, the journal serves as a critical platform for researchers, clinicians, and professionals seeking to disseminate and discuss innovative findings in these rapidly evolving areas. Featuring an impressive Q2 ranking in both Immunology and Allergy, as well as Rheumatology, this journal is recognized for its high-quality contributions, placing it among the top tier of academic publications. Operating without an open access model, CLINICAL AND EXPERIMENTAL RHEUMATOLOGY is headquartered in Pisa, Italy, and publishes articles that undergo rigorous peer review to ensure excellence in research. This journal is an invaluable resource for those dedicated to improving patient outcomes through evidence-based practice in rheumatology, immunology, and related fields.

RHEUMATOLOGY

Exploring New Horizons in Rheumatic Disease Management
Publisher: OXFORD UNIV PRESSISSN: 1462-0324Frequency: 12 issues/year

RHEUMATOLOGY, published by Oxford University Press, is a leading journal in the fields of Pharmacology and Rheumatology, recognized for its significant contribution to advancing the understanding and treatment of rheumatic diseases. With an impressive impact factor and ranking within the top quartiles for both medical pharmacology and rheumatology, this journal serves as an essential resource for researchers, clinicians, and healthcare professionals. The journal spans an extensive publication history, with contributions from 1952 to 1995 and from 1998 to 2024, reflecting its enduring commitment to disseminating high-quality research. The Open Access option allows for broader dissemination of knowledge, enhancing the visibility of groundbreaking studies. Positioned in the United Kingdom, RHEUMATOLOGY not only offers valuable insights into the latest therapeutic advancements and clinical guidelines but also fosters collaboration across disciplines, ensuring that practitioners stay at the forefront of innovation in the management of rheumatic conditions.